Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-125.10M
↓ 96% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-63.67M
Historical baseline
PeriodValueYoY Change
TTM$-125.10M-50.6%
2024$-83.06M-129.6%
2023$-36.18M-249.0%
2022$-10.37M-